Therapeutic Cultivars

Therapeutic Cultivars refer to cannabis lineages intentionally developed with consistent cannabinoid and terpene profiles that breeders associate with specific user experiences or wellness applications. These strains typically emerge from controlled breeding programs targeting stable expression of compounds like CBD, CBN, or particular terpene combinations rather than purely high-THC potency. The category encompasses both balanced THC:CBD ratios and CBD-dominant lines, often traced to foundational crosses like Charlotte's Web, Harlequin, or Cannatonic. Therapeutic cultivar development represents a significant shift in cannabis breeding away from single-compound maximization toward polypharmacological profiles. Documentation of these lineages varies widely; some breeders maintain detailed cultivation records while others rely on phenotypic selection without published cannabinoid testing.

Breeders working in therapeutic cultivars prioritize consistent minor cannabinoid expression and secondary metabolite profiles across generations, requiring multi-year stabilization and regular third-party testing. Selection for these traits often involves backcrossing to verified genetic sources and careful environmental control to maintain target cannabinoid ratios.